Roberto Visentin

15 papers B 1Journal 7Unranked 7
YearRankTypeTitle / Venue / Authors
2024 J jnl
Modeling Doxorubicin Pharmacokinetics in Multiple Myeloma Suggests Mechanism of Drug Resistance.
IEEE Trans. Biomed. Eng.
Roya Doshmanziari, Francesco Da Ros, Mario Mazzucato, Morten Gram Pedersen, Roberto Visentin
2024 J jnl
Tailoring the Padova Type 2 Diabetes Simulator for Treatment Guidance in Target Populations.
IEEE Trans. Biomed. Eng.
Roberto Visentin, Michele Schiavon, Jacopo Bonet, Michela Riz, Britta Wagenhuber, Chiara Dalla Man
2022 J jnl
A software interface for
Comput. Methods Programs Biomed.
Roberto Visentin, Claudio Cobelli, Chiara Dalla Man
2022 — conf
Glucose Controlin Type 2 Diabetes: In Silico Study of Sub-Optimal Adherence to Insulin Therapy.
ICSC
Roberto Visentin, Claudio Cobelli, Jochen Sieber, Chiara Dalla Man
2021 — conf
A Novel Method for Generation of In Silico Subjects with Type 2 Diabetes.
EMBC
Roberto Visentin, Mattia De Lazzari
2021 — conf
Modeling Pharmacokinetics of Doxorubicin in Multiple Myeloma Cells.
EMBC
Alberto Giaretta, Francesco Da Ros, Mario Mazzucato, Morten Gram Pedersen, Roberto Visentin
2020 — conf
In Silico Cloning of Target Type 2 Diabetes Population for Treatments Development and Decision Support
EMBC
Roberto Visentin, Michele Schiavon, Chiara Dalla Man
2020 J jnl
Modeling Subcutaneous Absorption of Long-Acting Insulin Glargine in Type 1 Diabetes.
IEEE Trans. Biomed. Eng.
Michele Schiavon, Roberto Visentin, Clemens Giegerich, Thomas Klabunde, Claudio Cobelli, Chiara Dalla Man
2019 J jnl
Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 Diabetes Simulator for In Silico Testing of MDI Therapies.
IEEE Trans. Biomed. Eng.
Roberto Visentin, Michele Schiavon, Clemens Giegerich, Thomas Klabunde, Chiara Dalla Man, Claudio Cobelli
2018 — conf
A Model of Acetaminophen Pharmacokinetics and its Effect on Continuous Glucose Monitoring Sensor Measurements.
EMBC
Michele Schiavon, Giada Acciaroli, Martina Vettoretti, Alberto Giaretta, Roberto Visentin
2018 — conf
Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator
EMBC
Roberto Visentin, Michele Schiavon, Clemens Giegerich, Thomas Klabunde, Chiara Dalla Man, Claudio Cobelli
2018 J jnl
Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results.
IEEE Trans. Biomed. Eng.
Chiara Toffanin, Roberto Visentin, Mirko Messori, Federico Di Palma, Lalo Magni, Claudio Cobelli
2017 B conf
A Hybrid Clustering Prediction for Type 1 Diabetes Aid: Towards Decision Support Systems Based upon Scenario Profile Analysis.
CHASE
Iván Contreras, Josep Vehí, Roberto Visentin, Martina Vettoretti
2016 J jnl
One-Day Bayesian Cloning of Type 1 Diabetes Subjects: Toward a Single-Day UVA/Padova Type 1 Diabetes Simulator.
IEEE Trans. Biomed. Eng.
Roberto Visentin, Chiara Dalla Man, Claudio Cobelli
2015 — conf
Incorporation of inhaled insulin into the FDA accepted University of Virginia/Padova Type 1 Diabetes Simulator.
EMBC
Roberto Visentin, Thomas Klabunde, Marshall Grant, Chiara Dalla Man, Claudio Cobelli